Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Quak

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|August 1, 1974
Studies on bovine leukemia. I. Establishment of type C virus producing cell linesA A Ressang, N Mastenbroek, J Quak, et al.
Cancer Research|September 15, 1993
MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neckA H Schrijvers, J J Quak, A M Uyterlinde, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 11, 2000
Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trialM A Van Bokhorst-de Van der Schuer, S I Langendoen, H Vondeling, et al.
Anticancer Research|July 1, 1996
Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancerG A van Dongen, R M Brakenhoff, C T ten Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
British Journal of Cancer|September 1, 1992
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgGM Gerretsen, A H Schrijvers, M van Walsum, et al.
Head & Neck|August 1, 1997
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complicationsM A van Bokhorst-de van der Schueren, P A van Leeuwen, H P Sauerwein, et al.
Cancer|August 3, 1999
The impact of nutritional status on the prognoses of patients with advanced head and neck cancervan Bokhorst-de van der Schuer, P A van Leeuwen, D J Kuik, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|August 1, 1974
Studies on bovine leukemia. I. Establishment of type C virus producing cell linesA A Ressang, N Mastenbroek, J Quak, et al.
Cancer Research|September 15, 1993
MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neckA H Schrijvers, J J Quak, A M Uyterlinde, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 11, 2000
Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trialM A Van Bokhorst-de Van der Schuer, S I Langendoen, H Vondeling, et al.
Anticancer Research|July 1, 1996
Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancerG A van Dongen, R M Brakenhoff, C T ten Brink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
British Journal of Cancer|September 1, 1992
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgGM Gerretsen, A H Schrijvers, M van Walsum, et al.
Head & Neck|August 1, 1997
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complicationsM A van Bokhorst-de van der Schueren, P A van Leeuwen, H P Sauerwein, et al.
Cancer|August 3, 1999
The impact of nutritional status on the prognoses of patients with advanced head and neck cancervan Bokhorst-de van der Schuer, P A van Leeuwen, D J Kuik, et al.
Pageof 9